A detailed history of Alpha Zero LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Alpha Zero LLC holds 519 shares of LLY stock, worth $530,262. This represents 0.23% of its overall portfolio holdings.

Number of Shares
519
Holding current value
$530,262
% of portfolio
0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$625.65 - $812.69 $324,712 - $421,786
519 New
519 $396 Million
Q2 2025

Nov 12, 2025

BUY
$713.71 - $898.95 $24,979 - $31,463
35 Added 9.26%
413 $322 Million
Q1 2025

Nov 12, 2025

SELL
$725.72 - $929.72 $23,948 - $30,680
-33 Reduced 8.03%
378 $312 Million
Q4 2024

Nov 12, 2025

SELL
$727.2 - $932.06 $78,537 - $100,662
-108 Reduced 20.81%
411 $317 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $971B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Alpha Zero LLC Portfolio

Follow Alpha Zero LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Zero LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Zero LLC with notifications on news.